n,n-dimethylarginine has been researched along with thioctic acid in 3 studies
| Studies (n,n-dimethylarginine) | Trials (n,n-dimethylarginine) | Recent Studies (post-2010) (n,n-dimethylarginine) | Studies (thioctic acid) | Trials (thioctic acid) | Recent Studies (post-2010) (thioctic acid) |
|---|---|---|---|---|---|
| 2,216 | 228 | 1,221 | 4,628 | 322 | 1,947 |
| Protein | Taxonomy | n,n-dimethylarginine (IC50) | thioctic acid (IC50) |
|---|---|---|---|
| Ubiquitin-like modifier activating enzyme 2 | Homo sapiens (human) | 2.68 | |
| SUMO1 activating enzyme subunit 1 | Homo sapiens (human) | 2.68 | |
| hexokinase | Trypanosoma brucei brucei TREU927 | 0.2008 | |
| SUMO-conjugating enzyme UBC9 | Homo sapiens (human) | 2.68 | |
| eukaryotic translation initiation factor 4 gamma 1 isoform 4 | Homo sapiens (human) | 16.56 | |
| eukaryotic translation initiation factor 4E isoform 1 | Mus musculus (house mouse) | 16.56 | |
| Vif | Human immunodeficiency virus 1 | 7.67 | |
| Tat | Human immunodeficiency virus 1 | 5.891 | |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 7.67 | |
| bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase | Mycobacterium tuberculosis H37Rv | 3.91 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, JW; Chun, S; Kim, SB; Kim, TH; Lee, EK; Lee, KU; Min, WK; Park, JS | 1 |
| Francesconi, M; Mittermayer, F; Pleiner, J; Wolzt, M | 1 |
| Choi, DS; Han, SM; Jung, CH; Kim, GH; Kim, SH; Kim, SW; Lee, KU; Lee, WJ; Park, HS; Park, JY; Won, JC | 1 |
2 trial(s) available for n,n-dimethylarginine and thioctic acid
| Article | Year |
|---|---|
Effects of alpha-lipoic acid on the plasma levels of asymmetric dimethylarginine in diabetic end-stage renal disease patients on hemodialysis: a pilot study.
Topics: Adult; Antioxidants; Arginine; Biomarkers; C-Reactive Protein; Cholesterol; Chromatography, High Pressure Liquid; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Kidney Failure, Chronic; Lipoproteins, LDL; Male; Middle Aged; Nitric Oxide Synthase; Oxidation-Reduction; Pilot Projects; Renal Dialysis; Thioctic Acid; Treatment Outcome | 2007 |
Treatment with alpha-lipoic acid reduces asymmetric dimethylarginine in patients with type 2 diabetes mellitus.
Topics: Arginine; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Male; Middle Aged; Thioctic Acid | 2010 |
1 other study(ies) available for n,n-dimethylarginine and thioctic acid
| Article | Year |
|---|---|
Alpha-lipoic acid activates dimethylarginine dimethylaminohydrolase in cultured endothelial cells.
Topics: Amidohydrolases; Animals; Arginine; Cell Line, Tumor; Endothelial Cells; Enzyme Induction; Mice; Promoter Regions, Genetic; STAT3 Transcription Factor; Thioctic Acid | 2010 |